CureVac exercises options in strategic collaboration with myNEO Therapeutics.

OUR LATEST POST

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

CureVac has exercised its options on a selected set of potential cancer vaccine targets identified by myNEO Therapeutics under the existing partnership agreement Two option fee payments triggered to myNEO Therapeutics By applying its AI-based ImmunoEngine platform,...

ALL POSTS

All

News

Press release

Article

Team events

Nov 22 2023

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

GHENT, Belgium and Tübingen, Germany/Boston, USA – November 22, 2023 – myNEO N.V. (myNEO Therapeutics) and CureVac N.V. (Nasdaq CVAC) announced t...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 25 2023

myNEO evolves into myNEO Therapeutics

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics. myNEO, a biotech company...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer and the p...

Sep 21 2023

myNEO Therapeutics Summer Cup

Congrats Lore Van Oudenhove, the winner of the first myNEO soccer cup! This summer we organised a table football cup where everyone of the team compet...

Aug 1 2023

Bloovi interview

At myNEO Therapeutics we are devoted to finding new and better targets for immunotherapy. With our validated technology, our amazing te...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer and the p...

Jun 1 2023

Review Trend in Cancer: Challenges in neoantigen-directed therapeutics

We are very happy to share our latest review paper! The power of personalized immunotherapy is becoming more and more apparent. The data pre...

May 1 2023

myNEO Tx academy launch

myNEO Therapeutics launches myNEO Tx academy on LinkedIn as we believe in the power of education! Each month we will touch upon a diffe...

Apr 1 2023

Cedric Bogaert selected in the Forbes 30under30 Europe List 2023

myNEO Therapeutics’ CEO, Cedric Bogaert, recently won a spot on the Forbes30under30 List 2023! We are very honored and excited about this achievemen...

Jan 12 2023

myNEO Therapeutics invited as speaker for a webinar about immunotherapy organized by LVV, a cancer patient organization

Lymfklierkanker Vereniging Vlaanderen (LVV) is organizing a webinar on January 28th where Lien Lybaert will explain in understandable l...

Nov 22 2023

CureVac exercises options in strategic collaboration with myNEO Therapeutics.

GHENT, Belgium and Tübingen, Germany/Boston, USA – November 22, 2023 – myNEO N.V. (myNEO Therapeutics) and CureVac N.V. (Nasdaq CVAC) announced t...

Oct 25 2023

myNEO evolves into myNEO Therapeutics

myNEO evolves into myNEO Therapeutics to reflect its new strategy to develop off-the-shelf cancer vaccine immunotherapeutics. myNEO, a biotech company...

Feb 13 2023

Odimma partners with myNEO Therapeutics for the clinical development of its personalized DNA-based cancer immunotherapy

Odimma Therapeutics and myNEO Therapeutics will partner to identify personalized targets for clinical development of DNA-based cancer vaccine therapy....

May 25 2022

CureVac Partners with myNEO Therapeutics to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

CureVac (Nasdaq: CVAC) and myNEO Therapeutics will partner to identify novel targets for mRNA-based cancer vaccine development. We’re convinced that...

Apr 7 2021

OncoDNA and myNEO Therapeutics Join Forces to Unlock the Power of Personalized Vaccines

Fighting Cancer with Personalized Vaccines: ONCODNA and myNEO Therapeutics collaboration OncoDNA, a company specializing in precision medicine, a...

Nov 16 2023

myNEO Therapeutic’s CEO Cedric Bogaert receives Medical Genetics award at the Vatican!

myNEO Therapeutics has been quite active in recent months, taking part in various conference presentations and participating in panel discussions. Add...

Oct 17 2023

Hookipa-HPV Case Study

Are AI-driven insights the future of precision medicine, reshaping clinical data analysis as we know it? The inherent complexity of cancer and the p...

Aug 1 2023

Bloovi interview

At myNEO Therapeutics we are devoted to finding new and better targets for immunotherapy. With our validated technology, our amazing te...

Nov 23 2022

Review publication in Cancer Cell

myNEO Therapeutics is extremely excited to announce the publication in the Cancer Cell journal, written by myNEO Therapeutics colleagues Lie...

Nov 14 2022

myNEO Therapeutics has won the 2022 Most Disruptive Innovator award

myNEO Therapeutics has won Deloitte’s 2022 Most Disruptive Innovator award. This award, which is part of the Rising Star category of the Deloitt...

Jun 21 2022

myNEO Therapeutics is growing its team and office

myNEO Therapeutics aims this year to double the team in size due to our growing project portfolio with multiple different partners. The data scie...

Sep 21 2023

myNEO Therapeutics Summer Cup

Congrats Lore Van Oudenhove, the winner of the first myNEO soccer cup! This summer we organised a table football cup where everyone of the team compet...

Jun 11 2023

Teambuilding 2023

Coming together is a beginning, staying together is progress, and working together is success! Just before summer we had a blast during the myNEO team...

May 10 2023

myNEO cocktail bar

Recently we enjoyed some delicious and freshly shaken, but not stirred, (m)(c)ocktails with the myNEO team. It was great catching up with everyone. #w...

Oct 13 2022

BBQ & breakfast

At myNEO we know a company is only as strong as its team! Therefore, we recently built on that team relationship. In August we both had a team-BBQ to...

Aug 17 2022

After work drinks @ gazon

Work hard, play hard!At myNEO we have afterwork drinks every month, this time we decided to enjoy the nice weather and have our well-deserve...

Mar 1 2022

After work drinks & dinner

myNEO fully endorses a work hard/play hard balance and so we have at least once a month an afterwork drink or dinner. We think it is importa...

Innovating immunotherapies,
transforming tomorrow

Subscribe to our newsletter

Get the latest news & updates about myNEO Therapeutics

Home

About us

Products

Technology

Partners

Services

Contact

Quick links

Publications

Latest news

Privacy statement

Terms of use

Careers

Cookie statement

We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.

myNEO Therapeutics

Ottergemsesteenweg 439
9000 Ghent
Belgium

Design by